Safety outcomes from the clinical development programme for lisdexamfetamine dimesylate: a prodrug stimulant for the treatment of attention-deficit/hyperactivity disorder

被引：0
|
作者：
Coghill, David [1 ]
Sorooshian, Shaw [2 ]
Caballero, Beatriz [2 ]
机构：
[1] Univ Dundee, Div Neurosci, Dundee, Scotland
[2] Shire AG, Clin Dev & Med Affairs, Eysins, Switzerland
来源：
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
PS-030
引用
收藏
页码：S224 / S224
页数：1
相关论文
共 50 条
  • [1] Lisdexamfetamine: A prodrug for the treatment of attention-deficit/hyperactivity disorder
    Popovic, Biljana
    Brattacharya, Pratik
    Sivaswamy, Lalitha
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (22) : 2005 - 2012
  • [2] Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder
    Faraone, Stephen V.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (09) : 1565 - 1574
  • [3] Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    Childress, Ann C.
    Cutler, Andrew J.
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Squires, Liza
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2011, 50 (04): : 395 - 405
  • [4] Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    Goodman, D.
    Adler, L.
    Kollins, S. H.
    Weisler, R.
    Krishnan, S.
    Zhang, Y.
    Biederman, J.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 292 - 293
  • [5] Lisdexamfetamine Dimesylate In Attention-Deficit Hyperactivity Disorder in Adults
    Weber, Juliane
    Siddiqui, M. Asif A.
    [J]. CNS DRUGS, 2009, 23 (05) : 419 - 425
  • [6] Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents
    Mattos, Paulo
    [J]. REVISTA DE PSIQUIATRIA CLINICA, 2014, 41 (02): : 34 - 39
  • [7] Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
    Childress, Ann C.
    Findling, Robert L.
    Wu, James
    Kollins, Scott H.
    Wang, Yi
    Martin, Patrick
    Robertson, Brigitte
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (03) : 128 - 136
  • [8] The Efficacy and Safety Profile of Lisdexamfetamine Dimesylate, a Prodrug of d-Amphetamine, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adults
    Najib, Jadwiga
    [J]. CLINICAL THERAPEUTICS, 2009, 31 (01) : 142 - 176
  • [9] Weight-related safety outcomes of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Lecendreux, Michel
    Zuddas, Alessandro
    Banaschewski, Tobias
    Soutullo, Cesar
    Bloomfield, Ralph
    Hodgkins, Paul
    Gasior, Maria
    Coghill, David
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S223 - S223
  • [10] Effect Size of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder
    Wigal, Timothy
    Brams, Matthew
    Gasior, Maria
    Gao, Joseph
    Giblin, John
    [J]. POSTGRADUATE MEDICINE, 2011, 123 (02) : 169 - 176
12345